- Home
- SAFT vs RXST Comparison
SAFT vs RXST Comparison
Compare SAFT & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAFT
- RXST
- Stock Information
- Founded
- SAFT 1979
- RXST 1997
- Country
- SAFT United States
- RXST United States
- Employees
- SAFT N/A
- RXST N/A
- Industry
- SAFT Property-Casualty Insurers
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SAFT Finance
- RXST Health Care
- Exchange
- SAFT Nasdaq
- RXST Nasdaq
- Market Cap
- SAFT 1.1B
- RXST 1.2B
- IPO Year
- SAFT N/A
- RXST 2021
- Fundamental
- Price
- SAFT $77.75
- RXST $29.60
- Analyst Decision
- SAFT
- RXST Strong Buy
- Analyst Count
- SAFT 0
- RXST 8
- Target Price
- SAFT N/A
- RXST $58.13
- AVG Volume (30 Days)
- SAFT 38.5K
- RXST 492.3K
- Earning Date
- SAFT 02-25-2025
- RXST 02-25-2025
- Dividend Yield
- SAFT 4.63%
- RXST N/A
- EPS Growth
- SAFT 139.36
- RXST N/A
- EPS
- SAFT 5.07
- RXST N/A
- Revenue
- SAFT $1,091,694,000.00
- RXST $128,293,000.00
- Revenue This Year
- SAFT N/A
- RXST $60.30
- Revenue Next Year
- SAFT N/A
- RXST $34.65
- P/E Ratio
- SAFT $15.33
- RXST N/A
- Revenue Growth
- SAFT 21.41
- RXST 67.52
- 52 Week Low
- SAFT $73.38
- RXST $26.29
- 52 Week High
- SAFT $90.00
- RXST $66.54
- Technical
- Relative Strength Index (RSI)
- SAFT 44.42
- RXST 33.54
- Support Level
- SAFT $76.43
- RXST $29.65
- Resistance Level
- SAFT $79.46
- RXST $32.25
- Average True Range (ATR)
- SAFT 1.39
- RXST 1.25
- MACD
- SAFT 0.04
- RXST -0.14
- Stochastic Oscillator
- SAFT 38.94
- RXST 4.66
About SAFT Safety Insurance Group Inc.
Safety Insurance Group Inc is a provider of private passenger automobile insurance in Massachusetts. The company also offers property and casualty insurance products, including commercial automobiles, homeowners, dwelling fire, umbrella, and business owner policies. It operates in the business segment of Property and casualty insurance operations.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.